Inventor · disambiguated record
Ali Fattaey
Also filed as: FATTAEY ALI · FATTAEY ALI R
8 granted patents·9 pending applications·252 citations·filing 1996–2017
88Inventor score
Files withONYX PHARMA INC7SAGRES DISCOVERY INC3MORRIS DAVID W2CURIS INC1SAGRES DISCOVERY INC A DELAWAR1
Top patents by PatentIndex Score
17 records- 0195US6498163B1Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferationWARNER LAMBERT CO·Filed 1998·Granted Dec 24, 2002·125 cites·44 claims
- 0292US7001596B1Oncolytic adenovirusONYX PHARMA INC·Filed 2000·Granted Feb 21, 2006·45 cites·11 claims
- 0388US7332281B2Therapeutic targets in cancerSAGRES DISCOVERY INC·Filed 2004·Granted Feb 19, 2008·42 cites·11 claims
- 0481US7396679B2Oncolytic adenovirusONYX PHARMA INC·Filed 2002·Granted Jul 8, 2008·9 cites·16 claims
- 0581US7078030B2Oncolytic adenovirusONYX PHARMA INC·Filed 2003·Granted Jul 18, 2006·21 cites·9 claims
- 0659US2009215711A1Novel compositions and methods in cancerSAGRES DISCOVERY INC·Filed 2004·Application pending·0 cites
- 0755US2003186881A1Nucleic acid sequences that encode a cell growth regulatory protein and uses thereofFiled 2003·Application pending·0 cites
- 0855US2008299561A1Novel therapeutic targets in cancerSAGRES DISCOVERY INC A DELAWAR·Filed 2007·Application pending·0 cites
- 0951US2009214546A1Novel therapeutic targets in cancerMORRIS DAVID W·Filed 2005·Application pending·0 cites
- 1049US5876711AMethods and compositions for determining the tumor suppressor status of cellsONYX PHARMA INC·Filed 1996·Granted Mar 2, 1999·10 cites·7 claims
- 1145US2018133223A1Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2017·Application pending·0 cites
- 1245US2003021768A1Viral mutants that selectively replicate in targeted human cancer cellsFiled 2002·Application pending·0 cites
- 1345US2007042385A1Novel compositions and methods in cancerSAGRES DISCOVERY INC·Filed 2005·Application pending·0 cites
- 1443US2003087847A1Method and reagent for the inhibition of checkpoint kinase-1 (Chk1) enzymeONYX PHARMA INC·Filed 2001·Application pending·0 cites
- 1538US2006024677A1Novel therapeutic targets in cancerMORRIS DAVID W·Filed 2004·Application pending·0 cites
- 1630US6391630B1Plasmids that encode green fluorescent proteinONYX PHARMA INC·Filed 1999·Granted May 21, 2002·0 cites·4 claims
- 1729US6558918B1Nucleic acid that encode a cell growth regulatory proteinONYX PHARMA INC·Filed 1997·Granted May 6, 2003·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Ali Fattaey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →